Please enable JS

White Paper Explores the Impact of Prior Authorization on Branded Medications

12/ 26

ARTICLE DETAILS

AUTHOR: 50SN Staff

DATE: Dec 26, 2017

TAGS:

SHARE ON: Twitter - Facebook - LinkedIn

White Paper Explores the Impact of Prior Authorization on Branded Medications

According to one analysis, approximately 70 percent of patients encountering a prior authorization do not receive the originally prescribed medication. Frost and Sullivan have produced a white paper that offers solutions for physicians, pharmaceutical companies and pharmacists to minimize delays and inefficiencies associated with the prior authorization process.

Read more.


 

Font Resize